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Abstract
Blood vessels and adjacent cells form perivascular stem cell niches in adult tissues. In this perivascular niche, a stem cell with
mesenchymal characteristics was recently identified in some adult somatic tissues. These cells are pericytes that line the
microvasculature, express mesenchymal markers and differentiate into mesodermal lineages but might even have the
capacity to generate tissue-specific cell types. Here, we isolated, purified and characterized a previously unrecognized
progenitor population from two different regions in the adult human brain, the ventricular wall and the neocortex. We show
that these cells co-express markers for mesenchymal stem cells and pericytes in vivo and in vitro, but do not express glial,
neuronal progenitor, hematopoietic, endothelial or microglial markers in their native state. Furthermore, we demonstrate at
a clonal level that these progenitors have true multilineage potential towards both, the mesodermal and neuroectodermal
phenotype. They can be epigenetically induced in vitro into adipocytes, chondroblasts and osteoblasts but also into glial
cells and immature neurons. This progenitor population exhibits long-term proliferation, karyotype stability and retention of
phenotype and multipotency following extensive propagation. Thus, we provide evidence that the vascular niche in the
adult human brain harbors a novel progenitor with multilineage capacity that appears to represent mesenchymal stem cells
and is different from any previously described human neural stem cell. Future studies will elucidate whether these cells may
play a role for disease or may represent a reservoir that can be exploited in efforts to repair the diseased human brain.
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Introduction
Mesenchymal stem cells (MSC) are the conceptual postnatal
progenitors of most derivatives of mesoderm [1,2]. They were
initially isolated from the bone marrow [3], but subsequently also
from several other tissues e.g. the umbilical cord, bone trabeculae,
muscle, synovium, dental pulp, periodontal ligament and adipose
tissue [1,4]. Mesenchymal stem cells are isolated by adherence to
plastic, and characterized by the expression of a panel of surface
markers [5] and their capacity to differentiate along mesodermal
lineages into adipocytes, chondroblasts and osteoblasts [3]. Until
recently, the exact in vivo identity of MSC was elusive. However,
now it has been suggested that MSC may reside in the perivascular
compartment and have characteristics identical to a subclass of
pericytes [4,6,7,8]. Pericytes reside on the abluminal surface of
endothelial cells in the perivascular space and span the entire
microvasculature. Not only are they important regulators of
angiogenesis and blood vessel function [9] they also contribute to
the pathogenesis of diabetic microangiopathy, cancer, atheroscle-
rosis and Alzheimer’s disease [10]. Akin to MSC, pericytes have
been reported to be able to differentiate into osteoblasts [11,12],
chondrocytes and adipocytes [13,14]. Observations in several
tissues suggest that they can contribute to tissue repair: pericytes
differentiate into adipocytes during fat tissue injury [15], into
chondroblasts and bone after bone injury [12], into myoblasts in
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testis [17]. Recent data in a mouse model show that pericytes have
the ability to contribute to spinal cord repair by differentiation into
astrocytes [18]. Interestingly, the highest density of pericytes is
found in the central nervous system [19] and it is not known
whether the human perivascular compartment harbors this
particular subclass of pericytes and whether this cell type has
stem cell properties.
Here, for the first time, we identify a perivascular stem cell in the
human adult brain. We isolate, purify and characterize cells from
human brain biopsies that resemble marker expression of the
perivascular progenitors found in vivo. We show that these cells
shareamesenchymalandpericytephenotypeandhavethepotential
to differentiate into mesodermal and neuroectodermal progeny.
Results
The adult human brain contains cells that co-express
mesenchymal and pericyte markers
We examined sections of the human neocortex for the presence
of cells expressing MSC markers. Cells positive for a-smooth
muscle antigen (a-SMA), a marker for smooth muscle cells and
pericytes [20] lined microcapillaries (Figure 1A). We identified
cells expressing the pericyte marker platelet-derived growth factor
receptor b (PDGFR-b) along the perivascular space [21,22]. A
subpopulation of PDGFR-b-positive pericytes co-expressed mar-
kers for MSC (CD105 and CD13) and was preferably situated at
vessel branching points (Figure 1B, C). The PDGFR-b-positive
pericytes located at the branching point of vessels also expressed
Ki67, a marker associated with cell proliferation (Figure 1D).
Interestingly, also the cells labeling for MSC markers were found
at branching points, suggesting that this is a proliferating
population. We therefore refer to these cells as perivascular
MSC hereafter.
Isolation, sorting and expansion of human mesenchymal
progenitor cells
Fresh tissue biopsies from the ventricular zone or the temporal
neocortex of the human brain were carefully enzymatically
dissociated, plated on plastic dishes and subjected to Fluores-
cence-activated cell sorting (FACS) once high enough cell numbers
had been obtained (Figure 2A, B). Within a few days after plating
the first proliferating adherent cells were visible (Figure 2C). Only
very few primary neural cells or cell aggregates were visible in
freshly plated cultures but were lost when the cell cultures had
been passaged twice. Passaging and replating on uncoated plastic
dishes selected for the adherent cell type (Figure 2D, E).
Cell lines from both the ventricular zone and the cortex
exhibited similar logarithmic growth expansion (Figure 2F) and
could be freeze-stored and thawed without losing their pro-
liferation capacity. We were able to efficiently long-term propagate
cells over many passages (up to passage 50 assessed so far). Long-
term expanded cells kept a normal karyotype (Figure 2G).
We used FACS to purify the cells. We sorted cell lines from all
donors by first positively gating for MSC markers CD13 and
CD105; and then negatively for the hematopoietic marker CD45
and the endothelial marker CD31. The
CD13
+CD105
+CD45
2CD31
2 population comprised 99.4–100%
oftheisolatedandpropagatedcellpopulationsirrespectiveofwhich
donortheyoriginatedfromandwhethertheywerederivedfromthe
ventricular zone or the neocortex (Figure 3A–D). Based on the
markerexpressionfoundinvitroweconcludedthattheisolatedcells
resemble the perivascular MSC in vivo.
Co-expression of mesenchymal and pericyte markers
We further investigated the antigenic profile ofthe cell lines using
flow cytometry analysis. Cell lines from all donors (n=4) expressed
severalMSCmarkers,suchasCD105(98.98%60.5),CD73(96.0%
62.9), CD90 (88.5% 65.2), CD29 (99.4% 60.2), CD166 (96.0%
62.4)andCD49d(89.2%64.1)butnotthemyoblastmarkerCD56
(4.4% 60.8) (Fig. 4A and B). Furthermore, the cell lines expressed
a panel of phenotypic markers currently used to identify pericytes
[8,16] such as PDGFR-b/CD140b [21,22] (97.8% 60.7), CD146
[8] (57.3% 67.3), regulator of G-protein signaling 5 (RGS5),
a marker selectively expressed in pericytes in brain capillaries [23]
(81.7% 612.1), Nestin [24] (94.1% 62.7), a-SMA [20] (96.6%
61.2) and high molecular weight melanoma-associated antigen
NG2 [25] (78.3% 621.5). Cells derived from the four different
donors neither expressed glial precursor markers such as O4 (1.4%
61.0) and glial fibrillary acid protein (GFAP, 3.1% 60.9) nor
hematopoietic (CD45, 1.4% 60.5), endothelial (CD31, 1.3% 60.4;
CD34, 1.4% 60.1) or microglial markers (CD11b, 1.1% 60.2;
CD14, 0.9% 60.2) (Fig. 4A, B).
Consistent with the flow cytometry analysis, using immunocyto-
chemistry we confirmed that cells expressed the pericyte markers
PDGFR-b/CD140b, RGS5, NG2 but not the glial precursor
marker O4. Cells co-labeled with a-SMA, Nestin and Kir6.1,
a marker specific for cerebral pericytes [26]. Results did not differ
between donors or region of origin (ventricular zone or neocortex).
Representative images from a ventricular donor line are presented
(Figure 5A–E). Furthermore, proliferating cell lines did not stain for
the neuralorglial precursorcell markers GLAST(astrocyte-specific
glutamate transporter), GFAP, S-100b or A2B5 (data not shown).
Characteristics of clonally derived progenitors
Next, we derived clones from all cell lines to investigate
differentiation properties of the brain-derived perivascular MSC
(Figure 6A). Single cell-derived clones were derived from all
donors with minimal variation in cloning efficacy (1–3%). Clones
had the same antigenic profile as FACS-sorted polyclonal cells
(Figure 6B). As cells were derived from the human brain,
expanded monoclonal cell lines from all donors were also
examined for the presence of mRNA for neural progenitor
markers to exclude that the population was derived from a neural
progenitor. The human neuronal progenitor line MesC2.10 [27]
served as a positive control. Single-cell derived clones expressed
high levels of mRNA for pericyte markers RGS5, PDGFR-b and
a-SMA compared to the human neuronal progenitors. As
expected, clonal lines derived from perivascular MSC and the
control neuronal progenitors expressed comparable levels for
Nestin and NG2 mRNA (Figure 6C). Both, Nestin and NG2 are
markers that are described for neuronal progenitors, but are also
well-recognized markers for pericytes [24,25,28] which explains
this overlap in marker mRNA. However, most importantly,
mRNA for the neuronal progenitor markers CD133, SOX1,
NGN2, PAX6 and Musashi was not detectable in any of the
monoclonal lines, but highly expressed in the control neuronal
progenitor line (Figure 6D).
Clonally derived perivascular MSC differentiate along the
mesodermal lineage
The fact that the brain-derived cells expressed MSC and
pericyte markers prompted us to investigate their mesodermal
potential. Using previously described protocols [8] we successfully
induced clonal lines from both the neocortex (n=6) and the
ventricular zone (n=4) to differentiate into osteoblasts, chondro-
cytes and adipocytes as evidenced by stainings with the typical
Multipotent Progenitors in the Adult Human Brain
PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e35577markers (Figure 7A–D). Control cultures in proliferation medium
did not stain for any of the markers (data not shown).
Furthermore, we observed a 8-fold upregulation of mRNA for
the adipose differentiation related protein (ADRP) in perivascular
MSC’s cultured in adipogenic medium compared to non-induced
control cultures (Figure 7E).
Clonally derived perivascular MSC differentiate along the
neuroectodermal lineage
Pericytes in different organs share a similar marker expression
profile. However, the tissue they reside in may influence their
differentiation capacity [7]. Therefore, we investigated if human
cerebralperivascularMSCcanadoptthephenotypeofcellsfoundin
the brain.
When clonal cell lines were cultured using a neuronal induction
protocol (see methods), mRNA for the neural markers double-
cortin (DCX), b-III-tubulin and GFAP was highly upregulated
compared to proliferating MSC, thus confirming the neuronal
induction (Figure 8A). In proliferating, non-induced cultures no
mRNA for neuronal markers was detected (Figure 8A, B). At the
same time mRNA for neuronal markers was upregulated in
cultures induced in neural induction medium, the expression of
the pericyte markers a-SMA, Nestin, RGS5, NG2 and PDGFR-
b was significantly decreased compared to proliferating controls
(Figure 8B). This was consistent with the changes in protein
expression seen by immunocytochemistry (Figure 8C).
We then investigated the expression of mRNA for different
neuronal transcription factors. Differentiating cells showed a sixfold
upregulation of the neuronal transcription factor Pax6, a twelvefold
increase in mRNA for NeuroD1, and a 73-and 42-fold upregula-
tion of Tbr2 and Tbr1, respectively, indicating a glutamatergic
phenotype (Figure 8C).
Next, we used immunocytochemistry to further investigate the
phenotype of differentiated cells. We used two different protocols.
When clonal cultures were grown in glial induction medium (see
methods) the majority of cells expressed the glial markers GFAP
and S100b (Figure 9A, B) and few cells the oligodendrocyte
marker O4 (Figure 9C). If exposed to neuronal induction medium
(see methods) for 7 days, cells stained for the immature neuronal
marker doublecortin (DCX) (Figure 9D). 10 days after neuronal
induction, cells expressed HUC/D (Figure 9E), neuron specific
enolase (NSE) (Figure 9F) and the immature neuronal marker b-
III-tubulin (Figure 9G, H, I). A proportion of those stained positive
for the pan-neuronal marker MAP2 (Figure 9H, h0). Exposure to
glial induction medium resulted in 40.9% 62.4 GFAP-positive
cells and 11.4%61.6 O4-positive cells, whereas in neuronal
induction medium, 30.4% 6 4.18 of the total number of cells
expressed TUJ1. The remaining cells continued to express
markers for proliferating cells. Few neuronal cells also labeled
with synaptophysin and PSD 95 (Figure 9G and data not shown).
Only very few cells (,1%) adopted a more mature neuronal
morphology and expressed GABAA-receptor (Figure 9I) but were
negative for dopaminergic, serotonergic or cholinergic markers.
Neuronal and glial cells could be derived from both regions, i.e.
the ventricular zone (4 clones analyzed) and the neocortex (6
clones analyzed).
We then used the patch-clamp technique to examine the
electrophysiological properties of clonally derived cells that
displayed a neuronal phenotype in comparison to undifferentiated
controls. Undifferentiated perivascular progenitor cells were
electrically silent under baseline conditions and failed to produce
Figure 1. The adult human brain contains perivascular cells co-expressing mesenchymal stem cell and pericyte markers. (A) Confocal
image showing neocortical brain section with intracerebral capillary with endothelial cells on the luminal side of the blood vessel (vWF, red)
surrounded by a-SMA-positive cells (green). Scale bar 100 mm. (B) Capillaries are lined with pericytes expressing PDGFR-b/CD140b (red) whereby
a proportion double labeled for the MSC markers CD 105 (green) and (C) CD13 (green). Scale bar 25 mm (B) and 17 mm (C). (D) PDGFR-b-positive cells
at vessel branching points stain for Ki67 (green). Scale bar 10 mm.
doi:10.1371/journal.pone.0035577.g001
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observed single-channel activity in differentiated cells with
immature neuronal morphology (Figure 9K). The mean open
time of the recorded channel openings was 8.161.5 ms with
a single channel current of 15.9 pA and a conductance of 214 pS
at 270 mV. Upon stimulation with high potassium, action
currents were observed in differentiated cells with neuronal
morphology (Figure 9M, m9).
Discussion
We have identified a previously uncharacterized multipotent
progenitor cell in the perivascular compartment of the adult
human brain. Using FACS purification, flow cytometry analysis,
immunocytochemistry and qPCR we determine that an isolated
progenitor cell exhibits a marker signature for both, MSC and
pericytes in vitro.
Perivascular cells and MSC have previously been linked
[8,13,29]. Recently it was suggested that the in vivo location of
MSC may be the perivascular niche and, that MSC may actually
represent a subclass of pericytes [6,7]. Consistent with this notion,
we identified cells expressing mesenchymal (CD105, CD13) and
pericyte markers (PDGFR-b) in a perivascular location in the adult
human brain, primarily around vascular branching points. This
population is dividing as indicated by Ki67 staining, a proliferation
marker.
We isolate, expand and positively sort the progenitors for
CD105 and CD13 and negatively for the hematopoietic marker
CD45 and the endothelial CD31. Thereby we show that the
isolated and expanded progenitor cells resemble the marker
expression of perivascular pericytes in vivo. We further demon-
strate that polyclonal and monoclonal cerebral perivascular MSC
are highly positive for pericyte and MSC markers but negative for
hematopoietic, endothelial, microglial and glial markers. We show
that clonally derived cerebral perivascular MSC can differentiate
along multiple mesodermal lineages in adipocytes, chondrocytes
and osteoblasts. This has not been reported for a human brain-
derived progenitor cell before, but is a known feature of both MSC
from other tissues [3] and pericytes [11,12,13,14].
Figure 2. Isolation and expansion of perivascular mesenchymal
stem cells from the adult human brain. (A) Progenitor cells were
isolated from fresh tissue biopsies from the ventricular wall (n=2) or
the temporal neocortex (n=2). (B) The tissue was enzymatically
digested and cells were plated and expanded as adherent monolayers.
Once sufficient cell numbers were reached cells were purified by FACS.
(C) Phase contrast image of morphology of adherent growing
progenitor cells 5 days after isolation from neocortical tissue and (D)
at confluency. (E) Cells have the typical flat morphology and large
nucleus with prominent nucleoli as described for perivascular cells.
Scale bars 50, 10, 100 mm. (F) Exponential growth characteristics of cell
lines from ventricular zone and the cortex. Progenitors exhibit similar
doubling time independent of region of origin. (G) Karyotype at
passage 39, showing euploid number of chromosomes following long-
term expansion. Data from representative culture from ventricular zone
donor line.
doi:10.1371/journal.pone.0035577.g002
Figure 3. FACS sorting of brain-derived progenitor cell lines.
Human progenitor cells were positively sorted for the MSC markers
CD105 and CD13, and thereafter negatively for hematopoietic (CD45)
and endothelial markers (CD31). Histogram illustrates results (A, B) for
the two different cortical lines and (C, D) for the two lines from the
ventricular zone. 99.4–100% of the cell population expressed both,
CD105 and CD13, and cultures did not contain endothelial or
hematopoietic cells.
doi:10.1371/journal.pone.0035577.g003
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precursors. (A) Representative histogram of flow cytometry analysis of cortical line and (B) ventricular zone line. Progenitors from all donors and
both regions highly express MSC (CD90, CD73, CD105, CD29, CD166 and CD49d) and pericyte markers (CD140b/PDGFR-b, RGS5, CD146, Nestin, a-
SMA and NG2). They do not express hematopoietic (CD45), endothelial (CD31, CD34), microglial (CD14, CD11), glial or neuronal precursor cell markers
(GFAP, O4) or myofibroblast markers (CD56), (green=isotype, red=respective marker).
doi:10.1371/journal.pone.0035577.g004
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observed in MSC from bone marrow when cells were exposed to
certain epigenetic signals [30,31,32,33,34], or when MSC were
genetically transduced [35]. Thus, MSC may have an inherent
potential to differentiate into multiple lineages if exposed to
appropriate epigenetic signals, although this capacity may differ
between different tissues of origin. Interestingly, under patholog-
ical conditions, a tissue-specific differentiation capacity of pericytes
has been observed. Pericytes differentiate into adipocytes during
fat tissue injury, or into chondroblasts, bone, myoblasts or Leydig
cells, depending on their location [12,15,16,17]. Recently,
pericytes have been shown to contribute to spinal cord repair by
differentiation into astrocytes [18]. Our findings support previous
data in primates and rodents that indicate the possible derivation
of neurons from pericytes in the central nervous system. Thus, it
was previously suggested that vascular adventitia may generate
neural progenitors after transient ischemia in monkeys [36] and
another study provided evidence in rats that isolated CNS
pericytes have the potential to become cells that express neuronal
markers [37].
We show using PCR and immunocytochemistry that perivas-
cular MSC derived from the human brain not only differentiate
into mesodermal lineages, but can be epigenetically induced to
differentiate along glial and neuronal lineages. Perivascular MSC
change morphology, downregulate pericyte markers and express
mRNA for neuronal transcription factors (Pax6, NeuroD1, Tbr2,
Tbr1) as well as for doublecortin and TUJ1. We also detect protein
expression, though to a low degree, of more mature neuronal
markers (HUC/D, NSE, Map2, synaptophysin, GABAA receptor)
upon epigenetic simulation. Using a glial induction protocol, cells
adopt a glial phenotype and express glial markers (GFAP, S100b,
O4). Thus, human cerebral perivascular MSC have the inherent
capability to generate glial cells and neuronal cells. The
differentiating cells clearly show changes in membrane properties
compared to proliferating cells indicating a change in phenotype
even though, under the culture conditions we explored, the
majority of cells have an immature neuronal phenotype and
immature membrane properties. A small percentage of cells
express markers resembling the phenotype of mature glutamater-
gic neurons, consistent with the mRNA expression of neuronal
transcription factors. Further studies are warranted to explore
whether these cells can be induced into fully mature, long-term
surviving, functionally active neurons.
The adult brain harbors neural/glial stem cells in specialized
niches [38]. Under physiological conditions, adult neurogenesis
occurs mainly in two regions: the subventricular zone and the
subgranular zone of the dentate gyrus of the hippocampus [39].
Stem cells in these regions share phenotypical features of radial glia
cells or astrocytes expressing GFAP or GLAST [40,41]. However,
neural stem cells have been derived from a variety of other adult
brain regions,yetitremainsunclear whether thesearesimilartothe
neural stem cells found in the subventricular zone and the
subgranular zone [42,43]. Human neural progenitor cells have
been isolated from several, also non-neurogenic regions
[44,45,46,47].
The perivascular MSC we isolated differ from those previously
described human neural stem cells. First, clonal perivascular MSC
from the adult human brain do not express mRNA for neural
progenitors such as GFAP, PAX6, Musashi, CD133, SOX1 or
NGN2 and do not exhibit early neuronal markers (doublecortin, b-
III-tubulin)whenproliferating.Itisthereforehighlyunlikelythatwe
have isolated one of the known neuronal or glial human progenitor
cell types. Second, the here characterized progenitor population
clearly exhibits a perivascular and mesenchymal phenotype.
Mesenchymal progenitors locate to the perivascular space, but are
not restricted to certain neurogenic brain regions. We could isolate
perivascularMSCfrombiopsiesfromtheventricularzoneandfrom
the neocortex and did not observe any difference in marker
expression or differentiation capacity. Third, in contrast to neural
stem cells, the isolated perivascular MSC have the capacity for both
neuroectodermal and mesodermal differentiation.
The described cerebral perivascular MSC can be efficiently
propagated long-term as adherent cultures, they show clonality,
have a stable karyotype and retain their full differentiation
capacity even following extensive proliferation. Thus, the isolated
human cerebral perivascular MSC fulfill the criteria for long-term
self-renewing stem cells in vitro [40].
In conclusion, we have demonstrated the presence of a pre-
viously uncharacterized stem cell in vivo in a perivascular location
in the human brain. We have shown that these perivascular
progenitors share a pericyte and mesenchymal phenotype, that
they can be isolated and that single cell-derived clones have the
Figure 5. Progenitor cells exhibit a pericyte phenotype in vitro. (A) Immunofluorescence image showing expression of PDGFR-b/CD140b, (B)
the pericyte-specific marker RGS5 and (C) expression of NG2 but absence of the oligodendroglial marker O4. Cells also co-express (D) Kir6.1, a marker
specific for cerebral pericytes (d9) and a-SMA (d0,e 0), and (E) Nestin (e9) as previously described for pericytes. Nuclei are stained with DAPI. Scale bars
50 mm.
doi:10.1371/journal.pone.0035577.g005
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PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e35577Figure 6. Characterisation of clonal perivascular MSC progenitor lines. (A) Single cell in vitro a few hours after plating, and culture at 7 and
21 days, respectively. Scale bar 50 mm. (B) Clonally derived MSC show the same antigen profile as detected for polyclonal lines with pericyte and MSC
markers but neither neuronal nor glial precursor cell markers (O4, GFAP) (example here cortical clone; green=isotype, red=respective marker).(C)
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dermal lineages in vitro. The in vivo function of this stem cell,
however, is unknown. Future studies will examine its role in the
vascular niche in the normal brain and, e.g., how it responds to
pathological conditions.
Materials and Methods
Human tissue
All procedures involving human tissue were performed with
informed written consent by the patient for the donation of brain
tissue and were approved by the ethical committees of the
Karolinska Hospital, Stockholm and Scania University Hospital,
Lund, Sweden. Brain tissue was harvested from individuals
undergoing surgery for ventriculostomy or shunt-placement
(n=2) or surgery for intractable temporal lobe epilepsy (n=2).
Immunohistochemistry
Cryosections (15 mm) of small human brain cortex pieces were
prepared and analyzed as described for human tissue sections [8].
Isolation and cell culture
Fresh tissue samples were stored in Leibowitz-15 media
(Invitrogen) at 4uC, cut and enzymatically digested in enzyme
solution (Collagenase 1 mg/ml (Sigma); Dispase 1.6 mg/ml
(Roche); Trypsin 0.25 mg/ml (Sigma); DNase I 80 U/ml (Sigma)
in Dulbecco’s modified Eagle Media (DMEM) and 4.5 mg/ml
glucose (Invitrogen) at 37uC/20 min. Cells were plated on 24-well
culture dishes and incubated at 37uC/5% CO2 in DMEM/F-12/
Glutamax/B27 (Invitrogen). Epidermal growth factor (EGF)
20 ng/ml (BD Biosciences), and human basic fibroblast growth
factor (bFGF) 20 ng/ml (Invitrogen) were added the day after
initial plating. After 7 days, cells were propagated in Stemline
medium (Sigma-Aldrich), 2% FBS (Invitrogen), 1% Penicillin/
Streptomycin (P/S) (Gibco) and 1% Glutamax (Gibco). Cells were
then expanded on uncoated culture flasks (Corning) without the
presence of mitogens.
FACS
For cell sorting, cells were incubated with anti-CD13-PECY7
(BD), anti-CD105-APC (Invitrogen), anti-CD31-FITC (BD),
CD45-PE (BD) at the concentration of 20610
6 cells/ml and
sorted by FACS (FACSAria; Becton Dickinson) or DIVA software
(Becton Dickinson) using a low stream speed to ensure a high level
of cell survival and in the four-way purity sorting mode to obtain
the highest purity of the sorted cells.
Flow Cytometry
Cultured cells were labeled at different passages with the
following commercial antibodies: anti-CD11b-PE, anti-CD14-
FITC, anti-CD29-PE-CY5, anti-CD31-FITC, anti-CD34-PerCP,
anti-CD45-FITC, anti-CD56-APC, anti-CD49d-PE, anti-CD90-
APC, anti-CD140b-PE, anti-CD146-FITC (all Serotec), anti-
CD166-PE, anti-CD105 (Invitrogen), anti-CD13-PECY7 and
anti-CD73-PE (BD), anti-a-SMA and anti-O4 (Sigma), anti-NG2
(Chemicon), anti-Nestin (Santa Cruz), anti-GFAP Alexa 647, anti-
RGS5 (Invitrogen), anti-Kir6.1 (Abcam). Isotype control immu-
noglobulins used were IgG1-PE, IgG1-FITC, IgG1-APC, IgG1-
PercP, IgG1-PECY7 (all from BD). Goat anti-mouse 488 and goat
anti-rabbit Alexa 488 were used for non-conjugated primary
antibodies. Resuspended cultured cells were stained as follows: For
detection of intracellular antigens, cells were fixed with ice-cold
methanol (Merck) and permeabilized with 0.05% Saponin (Sigma)
when necessary. After washing the cells twice with PBS containing
1% FBS cells were then incubated with the indicated primary
antibodies for 30 min on ice. Cells were washed twice, and 10,000
events were acquired on a FACSCalibur (BD).
Cloning
Clonal cell lines were established using limited dilution to 150
cells/ml and 10 ml placed into 48 wells that were inspected for the
presence of asingle cell 1 hlaterand supplemented withmedium to
the total volume of 300 ml. To determine the frequency of clones,
single cells were plated into 648 well plates and inspected for
presenceofsinglecellsasabove.Proliferatingcloneswerecountedas
successful once they could be expanded to a minimum of 250,000
cells.
Differentiation
For glial differentiation, cells were incubated for 10 days in
Neurobasal medium (Nb, Invitrogen), LIF (Leukemia inhibitory
factor, 10 ng/ml, Chemicon) and CNTF (Ciliary neurotrophic
factor, 10 ng/ml, R&D). For neuronal differentiation, cells were
grown in Nb medium containing 20 ng/ml PDGF (platelet-derived
growth factor) 300 mM, cAMP, 20 ng/ml SHH (sonic hedge hog)
and 5 ng/ml FGF2. Medium was supplemented every 48 hrs.
Foradipogenesis,cellsweregrowninDMEM,10%rabbitserum,
1 mM dexamethasone, 0.5 mM isobutylmethylxanthine, 60 mM
indomethacine, and 170 mM insulin (all Sigma). After 14 days, cells
QPCR comparing clones derived from the ventricular zone (n=2), and the cortex (n=2) to a human neuronal progenitor cell line MesC2.10. Data
show the relative higher expression of mRNA for RGS5, PDGFR-b and a-SMA in the MSC clones compared to the control. As expected, Nestin mRNA
was present in perivascular MSC clones and neural progenitors at comparable amounts. NG2 mRNA was slightly higher expressed in the MSC clones
compared to the control. (D) Importantly, neural progenitors markers such as CD133, SOX1, NGN2, PAX6 and Musashi were highly expressed in the
positive control but not detectable in MSC clones.
doi:10.1371/journal.pone.0035577.g006
Figure 7. Human brain-derived clonal MSC have mesodermal
potential. Clones derived from both, the ventricular zone (n=4) and
the cortex (n=6) can be induced to give rise to formation of
osteoblasts; (A) Alzarin S staining and (B) osteocalcin staining when
cultured in osteogenic medium for 21 days. (C) The same clone forms
chondrocytes if cultured as pellets (450 000 cells/pellet) in induction
medium. Image shows Safranin O Red staining of cortical-derived clone.
(D) Culture in adipogenic medium leads to lipid-containing adipocytes
after 14 days. Staining with Oil red illustrates accumulation of typical
lipids. (E) qPCR shows about 8-fold increase of adipose differentiation
related protein (ADRP) in cultures exposed to adipogenic differentiation
medium after 14 days compared to non-induced controls.
doi:10.1371/journal.pone.0035577.g007
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O (Sigma) for 10 min at room temperature (RT). For chondrogen-
esis, 450,000 cells were grown as pellets in serum-free DMEM with
insulin-transferrin-selenious (ITS) acid mix (Sigma), 50 mg/ml L-
ascorbic acid 2-phosphate (WAKO), 100 mg/ml sodium pyruvate
(Invitrogen), 0.1 mM dexamethasone (Sigma), and 10 ng/ml
transforming growth factor b3 (TGF-b3; R&D). After 21 days,
pellets were fixed, frozen, cut into 5 mm sections and stained with
Safranin O Red (Sigma). For osteogenesis, cells were cultivated in
RPIM, 10% horse serum (Gibco), 0.1 mM dexamethasone, 50 mg/
mLL-ascorbic acid,and 10 mMb-glycerophosphate (Sigma).After
21 days, cells were fixed in ice-cold 70% Ethanol and incubated for
30 min with alizarin red (pH 4.2) for the detection of calcium
deposits (all reagents from Sigma-Aldrich) or fixed in 4% PFA and
stained with osteocalcin (R&D).
Immunocytochemistry
For immunocytochemistry, cells were plated on glass coverslips
that were coated with Poly-L-lysine 90 mg/ml. Cultured cells were
fixed 5 min with ice-cold 50% acetone (Sigma Aldrich) and 50%
methanol (Fischer Scientific) or with 2% paraformaldehyde (PFA,
Sigma) at RT, washed in PBS and incubated for 1 h in PBS, 5%
donkey serum (PAA Laboratories). Cultured cells were then
stained for both primary and secondary antibodies in the presence
of 0.1% Triton X-100 (Sigma) and 2% donkey serum. Primary
antibodies: human-specific anti-Nestin (R&D, Chemicon), anti-
GFAP (DAKO), anti-b-III-tubulin (TUJ1) (BioSite), anti-NG2
(Chemicon), anti-a-SMA (Abcam; Sigma), anti-vWF (DAKO),
anti-DCX (Chemicon; Cell-Signaling), anti-MAP2 (Sigma), anti-
CD31 (DAKO, BD), anti-Synaptophysin (kindly provided by R.
Jahn), anti-O4 (Sigma), anti-GABAA-receptor (Millipore); anti-
TH (Millipore), anti-Serotonin (Chemicon), Anti-ChAT (Chemi-
con), anti-CD105 (BD), anti-CD13 (BD), anti-Ki67 (DAKO), anti-
PDGFR-b (Cell signaling), anti-RGS5 (Invitrogen), anti-Kir6.1
(Abcam), anti-A2B5 (Chemicon), anti-S100b (Sigma) and anti-
PSD 95 (Abcam).
Secondary antibodies: horse-anti-mouse FITC (Vector), donkey-
anti-rabbit CY3 (Jackson Immuno Research), donkey-anti-goat
FITC (Jackson Immuno Research), goat-anti-mouse IgM FITC
(Jackson Immuno Research), biotinylated anti-sheep (Vector
laboratories); biotinylated anti-rabbit (Vector laboratories), goat
anti-mouse Alexa Fluor 488, goat anti-mouse Alexa Fluor 594, goat
anti-rabbit Alexa Fluor 488 and Alexa Fluor 594 and donkey anti-
Figure 8. Human brain-derived clonal MSC upregulate immature neuronal markers and downregulate pericyte markers upon
neuronal induction. QPCR in neural induction cultures. (A) After 10 days of neuronal induction, we observed a 180–200 fold upregulation of mRNA
of the early neuronal markers DCX and b-III-tubulin and an about 50-fold increase in mRNA for GFAP, a glial marker and marker for neural progenitors.
(B) At the same time, mRNA expression for pericyte markers Nestin, a-SMA, RGS5 and PDGFR-b decreased compared to undifferentiated controls. (C)
Immunofluorescence image of neuronal induction culture showing TUJ1-positive cells and a-SMA-expressing cells. (D) QPCR showing upregulation of
neuronal transcription factors. There was a more than 6-fold upregulation in PAX6, tvelve-fold upregulation of NeuroD1, seventy three-fold
upregulation of Tbr2 and forty two-fold upregulation of Tbr1 compared to undifferentiated cells.
doi:10.1371/journal.pone.0035577.g008
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used.
PCR
For real-time qPCR, five-hundred nanograms of total RNA
from each sample were used for Oligo(dT)16 reverse transcription
using the AmpliTaq GoldH DNA polymerase first-strand synthesis
system for RT-PCR (Applied Biosystems). qPCR reactions with
synthesized cDNAs were performed on ABI Prism 7100 (Applied
Biosystems) using SYBR Green QPCR Master Mix (Fermentas).
mRNA levels were normalized using large ribosomal protein as an
internal control. Primer sequences are provided on request.
Karyotyping
Cells from several donors were karyotyped at early, medium
and late passage. Cells plated in t25 flasks were harvested using
0.05% trypsin (Sigma, Sweden), and G-banding of chromosomes
was obtained with Wright’s stain, according to standard
procedures. The clonality criteria and the description of the
karyotype were according to the recommendations of the ISCN
1995. For each karyotype analyzed, seven different metaphase
spreads were examined.
Figure 9. Human brain-derived clonal mesenchymal stem cells have neuroectodermal potential. (A) Image shows GFAP-staining, (B)
S100b-staining and (C) O4-staining after differentiation in glial induction medium. (D) If cells were exposed to neuronal induction protocol, cells stain
positive for doublecortin (DCX). Ten days after neuronal induction, differentiating cells express HUC/D (E), neuron-specific enolase (NSE) (F) and the
early neuronal marker b-III-tubulin (TUJ1) (G, H, h9,I ,i 9). Few cells express synaptophysin (G) and the pan-neuronal marker Map2 (H, h0). A few TUJ1-
positive cells express GABAA-receptor (I, i0). Scale bars 50 mm. (J) Patch clamp recording of membrane currents using the cell-attached mode, in
undifferentiated control cells. Note the absence of single-channel activity. (K) In contrast, single channel activity recorded in a cell differentiated in
neural induction medium for 7 days. (L) Absence of electrical responses in a depolarized control cell. (M) Action currents, reflected as the first
derivative of the membrane current, recorded in a depolarized differentiated cell. Several action currents are magnified in (m9). Data shown are
representative of 5 experiments in differentiated and undifferentiated cells.
doi:10.1371/journal.pone.0035577.g009
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Images were acquired using either Olympus BX60, Olympus
IX70 or Leica DMRBE fluorescence microscopes. Images were
captured with digital cameras (Olympus DP50 and Hamamatsu
C4742-95) and processed using studio and Openlab softwares.
Confocal microscopy was performed using a Leica microscope
equipped with a GreNe and a HeNe laser, using the following lines
of excitation: 488 nm, 594 nm and 647 nm. Figures were
composed using CANVAS software. Cells were counted in
triplicate cultures in randomly chosen areas under the microscope.
A minimum of 100 cells/experiment was assessed. Cell numbers
are expressed as mean standard deviation (SD).
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